{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T03:57:06Z","timestamp":1789963026228,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["P41 GM103314"],"award-info":[{"award-number":["P41 GM103314"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["P41 GM109824"],"award-info":[{"award-number":["P41 GM109824"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100002160","name":"Jain Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002160","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013961","name":"Robertson Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013961","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jim.2016.01.006","type":"journal-article","created":{"date-parts":[[2016,1,9]],"date-time":"2016-01-09T07:16:14Z","timestamp":1452323774000},"page":"56-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Optimizing selection of large animals for antibody production by screening immune response to standard vaccines"],"prefix":"10.1016","volume":"430","author":[{"given":"Mary K.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Fridy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Keegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Chait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Feny\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Rout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2016.01.006_bb0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0165-2427(92)90011-E","article-title":"Antibody avidity in Yorkshire pigs of high and low immune response groups","volume":"31","author":"Appleyard","year":"1992","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.jim.2016.01.006_bb0010","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1128\/JCM.19.4.447-452.1984","article-title":"Estimation of rotavirus immunoglobulin G antibodies in human serum samples by enzyme-linked immunosorbent assay: expression of results as units derived from a standard curve","volume":"19","author":"Bishop","year":"1984","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jim.2016.01.006_bb0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4049\/jimmunol.39.3.207","article-title":"The elimination of horse-serum specificity from antitoxins","volume":"39","author":"Coghill","year":"1940","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2016.01.006_bb0020","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fcimb.2014.00142","article-title":"Unconventional animal models: a booster for new advances in host-pathogen interactions","volume":"4","author":"Conti","year":"2014","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jim.2016.01.006_bb0025","first-page":"35","article-title":"Improving the dromedary antibody response: the hunt for the ideal camel adjuvant","volume":"18","author":"Eckersley","year":"2011","journal-title":"J. Camel Pract. Res."},{"key":"10.1016\/j.jim.2016.01.006_bb0030","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/nmeth.3170","article-title":"A robust pipeline for rapid production of versatile nanobody repertoires","volume":"11","author":"Fridy","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jim.2016.01.006_bb0035","series-title":"Methods in Immunology : A Laboratory Text for Instruction and Research","author":"Garvey","year":"1977"},{"key":"10.1016\/j.jim.2016.01.006_bb0040","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jim.2016.01.006_bb0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/ilar.37.3.93","article-title":"Review of polyclonal antibody production procedures in mammals and poultry","volume":"37","author":"Hanly","year":"1995","journal-title":"ILAR J."},{"key":"10.1016\/j.jim.2016.01.006_bb0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00253-007-1142-2","article-title":"Properties, production, and applications of camelid single-domain antibody fragments","volume":"77","author":"Harmsen","year":"2007","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.jim.2016.01.006_bb0055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nri977","article-title":"A road less travelled: large animal models in immunological research","volume":"3","author":"Hein","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jim.2016.01.006_bb0060","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/19420862.2015.1046648","article-title":"Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform","volume":"7","author":"Klarenbeek","year":"2015","journal-title":"MAbs"},{"key":"10.1016\/j.jim.2016.01.006_bb0065","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0264-410X(96)00294-0","article-title":"Antibody response to actinobacillus pleuropneumoniae antigens after vaccination of pigs bred for high and low immune response","volume":"15","author":"Magnusson","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2016.01.006_bb0070","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/10495399209525776","article-title":"Use of estimated breeding values in a selection index to breed Yorkshire pigs for high and low immune and innate resistance factors","volume":"3","author":"Mallard","year":"1992","journal-title":"Anim. Biotechnol."},{"key":"10.1016\/j.jim.2016.01.006_bb0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.vaccine.2007.10.064","article-title":"Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines","volume":"26","author":"Miura","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2016.01.006_bb0080","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","article-title":"Nanobodies: natural single-domain antibodies","volume":"82","author":"Muyldermans","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jim.2016.01.006_bb0085","first-page":"1","article-title":"Compendium of animal rabies prevention and control, 2011","volume":"60","author":"National Association of State Public Health Veterinarians, I.","year":"2011","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.jim.2016.01.006_bb0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1586\/14760584.5.1.33","article-title":"Human leukocyte antigen polymorphisms: variable humoral immune responses to viral vaccines","volume":"5","author":"Ovsyannikova","year":"2006","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jim.2016.01.006_bb0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.smim.2013.04.007","article-title":"Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century","volume":"25","author":"Poland","year":"2013","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jim.2016.01.006_bb0100","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.3390\/toxins5112138","article-title":"Clostridium perfringens epsilon toxin: a malevolent molecule for animals and man?","volume":"5","author":"Stiles","year":"2013","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.jim.2016.01.006_bb0105","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cell.2014.03.031","article-title":"Global analyses of human immune variation reveal baseline predictors of postvaccination responses","volume":"157","author":"Tsang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jim.2016.01.006_bb0110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vaccine.2009.09.094","article-title":"A review of the international issues surrounding the availability and demand for diphtheria antitoxin for therapeutic use","volume":"28","author":"Wagner","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2016.01.006_bb0115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/0003-4819-125-3-199608010-00012","article-title":"Heterologous antisera and antivenins are essential biologicals: perspectives on a worldwide crisis","volume":"125","author":"Wilde","year":"1996","journal-title":"Ann. Intern. Med."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175916300059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175916300059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T12:26:52Z","timestamp":1692188812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175916300059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":23,"alternative-id":["S0022175916300059"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2016.01.006","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing selection of large animals for antibody production by screening immune response to standard vaccines","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2016.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}